Indirect CalorimetryNCT05008757
Comparison of Indirect Calorimetry by Q-NRG With Deltatrac II
An observational study of Indirect Calorimetry, run by University of Liege at 1 site in Belgium.
Trial summary
Comparison of indirect calorimetry by Q-NRG (Cosmed) with Deltatrac II (Datex) Read more about this study
- Who is it for?
- Ages 18 to 40 yearsHealthy volunteers can take part
- Conditions the study is for
- Indirect Calorimetry
- What is being tested?
- no drug
- How many people
- 60 participants
- Where
- 1 siteBelgium
- Study dates
- 31 Aug 2021to 1 Jul 2023
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 40 years
- All sexes
- Healthy volunteers accepted
- Adult
Study population: Healthy volunteers who practice more than 1 hour per day at moderate intensity
Who may be able to join
- healthy adult
- sport practice > 1h per day at moderate intensity
Who cannot join
- refusal to participate
- unable to give a consent
Trial locations and contacts
1 site in 1 country.
Belgium1 site, 1 recruiting
- Recruiting
Marjorie Fadeur
Liège, 4000
Marjorie Fadeur, +3243662942, marjorie.fadeur@chuliege.be
About this study
Official title: Comparison of Indirect Calorimetry by Q-NRG With Deltatrac II in Healthy Volunteers
Comparison of indirect calorimetry by Q-NRG (Cosmed) with Deltatrac II (Datex)
Read the detailed description
The aim of the present study is to compare the measured resting energy expenditure by Q-NRG (Cosmed) with Deltatrac II (Datex), in healthy volunteers.
Q-NRG is a new device. It is relevant to compare its results with the blog standard calorimeter, the Deltratrac II.
The study will include sports healthy subjects. The could benefit from the determination of their resting energy expenditure in order to adapt their nutritional intakes.
- Conditions
- Indirect Calorimetry
- Being tested
- no drug
- Keywords
- indirect calorimetry
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
no drugOther
no intervention
What is being measured
The primary outcome is the main question the study is designed to answer.
resting energy expenditure
comparison of resting energy expenditure measured using Q-NRG calorimeter with resting energy expenditure measured using Deltatrac II
Measured: during the calorimetry
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted17 Aug 2021
- Study start31 Aug 2021
- Primary completion30 Apr 2022
- Study completion1 Jul 2023 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Indirect CalorimetryStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 60 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University of Liege
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Anne-Françoise Rousseau, University of Liege
- Investigators
- Anne-Françoise Rousseau, MD, PhD, Principal investigator, University Hospital of Liège, Belgium
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05008757
- Sponsor's protocol ID
- B7072021000024
- Status last verified
- Jun 2023
- First submitted
- 9 Jul 2021
- Last updated
- 27 Jun 2023
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 27 Jun 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Comparison of Indirect Calorimetry by Q-NRG With Deltatrac II in Healthy Volunteers
- ClinicalTrials.gov ID
- NCT05008757
- Acronym / sponsor ID
- B7072021000024
- Conditions
- Indirect Calorimetry
- Keywords
- indirect calorimetry
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 60 participants (estimated)
- Lead sponsor
- University of LiegeUniversity, hospital or other
- Study start
- 31 Aug 2021 (actual)
- Primary completion
- 30 Apr 2022 (actual)
- Study completion
- 1 Jul 2023 (estimated)
- First posted
- 17 Aug 2021 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Comparison of indirect calorimetry by Q-NRG (Cosmed) with Deltatrac II (Datex)
Detailed description
The aim of the present study is to compare the measured resting energy expenditure by Q-NRG (Cosmed) with Deltatrac II (Datex), in healthy volunteers.
Q-NRG is a new device. It is relevant to compare its results with the blog standard calorimeter, the Deltratrac II.
The study will include sports healthy subjects. The could benefit from the determination of their resting energy expenditure in order to adapt their nutritional intakes.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
Who may qualify
- Ages
- 18 to 40 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult
- Study population
- Healthy volunteers who practice more than 1 hour per day at moderate intensity
Key inclusion criteria (2 listed)
- healthy adult
- sport practice > 1h per day at moderate intensity
Key exclusion criteria (2 listed)
- refusal to participate
- unable to give a consent
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| no drugno intervention | Other | – |
Primary outcome
resting energy expenditure
Time frame: during the calorimetry
comparison of resting energy expenditure measured using Q-NRG calorimeter with resting energy expenditure measured using Deltatrac II
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 27 Jun 2023.
- Individual participant dataSharing planned: No
Related trials for Indirect Calorimetry
RecruitingPhase 4
Mechanisms of Weight Loss: Tirzepatide vs Semaglutide
Obesity (Disorder)
Active, not recruitingObservational study
Resting Metabolic Rate in Bodybuilders Using Performance-Enhancing Drugs
Athlete Assessment, Body Composition
Not yet recruiting
Inter-Individual Variability in Early Diet-Induced Thermogenesis After a Standardized Meal
Diet-induced Thermogenesis
RecruitingObservational study
Within-Individual Variability of Resting Metabolic Rate Over 12 Weeks
Resting Metabolic Rate, Energy Metabolism
Recruiting
Effects of Pre-Run Nutritional Supplements During a Fixed-Pace 5 km Treadmill Run
Exercise Physiology, Nutritional Supplementation
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Anne-Françoise Rousseau, MD, PhD principal investigator
University Hospital of Liège, Belgium
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Indirect Calorimetry, run by University of Liege at 1 site in Belgium.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 27 Jun 2023. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Belgium. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Marjorie Fadeur, RD (+33042843413, marjorie.fadeur@chuliege.be), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
resting energy expenditure (time frame: during the calorimetry). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Jun 2023.